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Comments on “Recent
Developments in Low-Level
Lead Exposure and Intellectual
Impairment in Children”
We commend Koller et al. (2004) for their
thoughtful and detailed review of recent
research on childhood lead exposure and
intellectual development, and we take this
opportunity to clarify and respond to sev-
eral of their questions regarding our study
of children with blood lead concentrations
< 10 µg/dL) (Canfield et al. 2003). 
The children in our cohort were
recruited between 24 and 30 months of age,
and all had participated in a prior random-
ized dust control trial (Lanphear et al.
1999). In that trial, dust and blood lead
concentrations were assessed at 6, 12, 18,
and 24 months of age as part of an evalua-
tion of whether dust control measures
reduced children’s blood lead concentra-
tions. Koller et al. (2004) raised several
questions related to whether children’s par-
ticipation in the prior study affected the
results we reported (Canfield et al. 2003).
Specifically, their concerns related to con-
founding, where an imbalance in the
distribution of intervention/control partici-
pants across levels of blood lead and IQ
could bias the association between blood
lead concentrations and IQ.
Our statistical model was developed
a priori and included covariates that were
established predictors of children’s intelli-
gence (Canfield et al. 2003). Because home
visitation by a dust control team (inter-
vention) seemed unlikely to increase chil-
dren’s IQ and because children who
participated in the intervention actually had
slightly lower IQ scores at 3 and 5 years of
age compared with controls, intervention
status was not considered a plausible con-
founder. To demonstrate that participation
in the dust control trial did not introduce
any bias of consequence and to illustrate
our basis for excluding intervention status
from our published models, in this letter we
summarize results for a semiparametric
spline model, which is identical to the one
we reported previously (Canfield et al.
2003) except for the inclusion of interven-
tion status as a potential confounding fac-
tor. The estimated decline in IQ as blood
lead concentration increases from 1 to
10 µg/dL is 6.8 points when controlling for
intervention status. This estimate is not
meaningfully different from the 7.4-point
decline we reported previously (Canfield
et al. 2003). Furthermore, the shape of the
dose–response function is preserved, with a
steeper slope at lower blood lead concentra-
tions. Estimates of the predicted decline in
IQ from parametric models with linear and
quadratic terms for blood lead also differ by
< 10% from the reported results (Canfield
et al. 2003) when intervention status is
included in the model. 
Additionally, Koller et al. (2004) sug-
gested that the Stanford-Binet IV Test of
Intelligence (SBIV) may not have provided
the most accurate estimate of IQ for our
cohort because of the relative weighting of
verbal and nonverbal skills that are assessed
and because of problems with the standard
method of dealing with zero-scored subtests.
Koller et al. (2004) suggested that the
Wechsler Primary and Preschool Scales of
Intelligence (WPPSI) would have yielded a
more reliable and valid measure of intelli-
gence. We first note that despite many
attractive features of the WPPSI (and espe-
cially of the WPPSI-Revised, which we con-
sidered using), the SBIV has features that we
believe made it a superior test for our partic-
ular cohort. Most importantly, the SBIV can
be administered to 2-year-olds, whereas the
youngest age for the WPPSI-R is 3 years.
Because our sample was predominantly com-
posed of families with lower parental educa-
tion and income, we preferred the test with
the lower floor. 
With respect to how zero-scored subtests
are handled, we indeed followed the stan-
dard scoring procedure for the SBIV, which
states that a zero score “should not be
included in the determination of the related
Area Score or of the Composite Score”
(Delaney and Hopkins 1987). Because this
scoring method was used in the standardiza-
tion of the instrument, a different approach
would yield scores with unknown psycho-
metric properties and thereby compromise
interpretation of the results. 
Nevertheless, any particular scoring
method has its weaknesses, and we agree that
it would be useful to know whether our
results change markedly by incorporating
information about zero scores. We therefore
added as a time-varying covariate in our
mixed models the number of subtests on
which each child scored zero. In the semi-
parametric spline model, the estimated
decline in IQ as blood lead concentration
increased from 1 to 10 µg/dL was 6.3 points.
Estimates from parametric models with lin-
ear and quadratic terms for blood lead dif-
fered by < 5% from the results we reported
previously (Canfield et al. 2003). Thus, the
incorporation of information about zero-
scored subtests did not change our results
markedly. 
Potential sources of confounding and
misclassification need to be carefully consid-
ered in the design and analysis phase of any
study, observational or otherwise, and in the
interpretation of results. The detailed atten-
tion given to these issues by Koller et al.
(2004) has allowed us the opportunity to
provide additional information about our
methods and results and thereby address
these methodologic issues.
Bruce P. Lanphear has acted as an expert wit-
ness for several plaintiffs in lead cases, but he has
not received financial remuneration; instead, any
payment has been donated directly to the
Cincinnati Children’s Hospital Medical Center.
The other authors declare they have no competing
financial interests.
Todd A. Jusko
Department of Epidemiology
University of Washington
Seattle, Washington
E-mail: jusko@u.washington.edu
Richard L. Canfield
Division of Nutritional Sciences
Cornell University
Ithaca, New York
Charles R. Henderson, Jr.
Department of Human Development
Cornell University
Ithaca, New York
Bruce P. Lanphear
Cincinnati Children’s Hospital 
Medical Center
Cincinnati, Ohio 
REFERENCES
Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C,
Jusko TA, Lanphear BP. 2003. Intellectual impairment in
children with blood lead concentrations below 10 microg
per deciliter. N Engl J Med 348:1517–1526.
Delaney DA, Hopkins TF. 1987. The Stanford-Binet Intelligence
Scale: Fourth Edition Examiner’s Handbook. Chicago:The
Riverside Publishing Company.
Koller K, Brown T, Spurgeon A, Levy L. 2004. Recent develop-
ments in low-level lead exposure and intellectual impair-
ment in children. Environ Health Perspect 112:987–994.
Lanphear BP, Howard C, Eberly S, Auinger P, Kolassa J,
Weitzman M, et al. 1999. Primary prevention of childhood
lead exposure: a randomized trial of dust control.
Pediatrics 103:772–777.
Low-Level Lead Exposure and
Intellectual Impairment in
Children: Koller et al.
Respond
We are grateful to Jusko et al. for addressing
two concerns raised in our review (Koller
et al. 2004) relating to confounding and their
use of the Stanford-Binet test in their original
report (Canfield et al. 2003). They provide
valuable additional analysis of their data,
which further support their original findings. 
Of relevance to the area of confounding
is a recent publication by Mink et al. (2004)
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in which the effects of different combina-
tions of confounders on multivariate analyses
of neurobehavior and neurotoxic exposure
were studied. Taking maternal intelligence,
home environment, and socioeconomic sta-
tus as the three most important confounders
in this field, Mink et al. urged caution in
associating small differences in IQ score in
the range of 3–10 points with the effects of
environmental exposure; they also made a
strong case for a priori consideration and
planning for all potential confounders in
epidemiological studies. As Jusko et al.
explain, this is indeed the method they used
in their original analyses (Canfield et al.
2003).
We feel that the weight of evidence
across a number of studies has come down
in support of an effect of low-level lead
exposure on children’s intellectual and
neurobehavioral function; as stressed by
Bellinger (2004), this evidence is supported
by studies on experimental animals in
which confounding is largely irrelevant.
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TCDD and Puberty in Girls
We would like to comment on the article by
Warner et al. (2004), in which the authors
reported no significant associations between
age at menarche and exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), an
extremely potent antiestrogenic xenobiotic.
The exposure of girls to TCDD at Seveso,
Italy, resulted in very high serum TCDD
levels (> 100 pg/g lipid), 10–100 times levels
usually seen today. Warner et al. noted that
the literature is mixed regarding the agonist/
antagonist effects in humans of persistent
exposures of this type. First, polybrominated
biphenyl exposures have been associated
with earlier menarche in girls, whereas
experimental models show delayed puberty,
a discordance that may be due to timing of
exposure (Blanck et al. 2000). Second, as
Warner et al. (2004) noted, the experimen-
tal data show that TCDD and other estro-
gen antagonists delay vaginal opening (VO)
and disrupt cyclicity in rodents treated pre-
natally (Gray et al. 1997; Levy et al. 1995).
However, hormonal activity depends on
both timing and level of dose, such that
phytoestrogens, for example, may be estro-
genic—hastening VO—at high doses given
after birth (Lamartiniere et al. 1995;
Whitten et al. 1995).
Epidemiologic data regarding hormon-
ally dependent female cancer are equivocal,
such that there have been suggestions of a
protective (i.e., antiestrogenic) effect of
TCDD for breast and uterine cancer in
TCDD-exposed women from Seveso
(Bertazzi et al. 2001), whereas a carcino-
genic effect has been observed in cohorts
exposed for longer times (Manz et al. 1991;
Warner et al. 2002). The findings of
Warner et al. (2004), albeit not statistically
significant, suggest earlier menarche with
higher TCDD level among women who
were younger than 8 years of age at the time
of exposure [hazard ratio, 1.08 for 10-fold
increase in TCDD levels; 95% confidence
interval (CI), 0.89–1.30) but not among all
women regardless of age. The study popula-
tion appears to have the usual patterns of
risk for menarche as indicated by associa-
tions that occur in the expected directions
[e.g., for Seveso zone, body mass index
(BMI), physical activity, alcohol intake].
Also, TCDD levels were higher among
younger girls (median, 205 ppt) than in all
girls (median, 140 ppt), an effect that may
reflect lower BMI among younger girls and
dilution of body burden by greater body
size in older girls, but also a significantly
higher target-organ dose. 
Warner et al. (2004) examined associa-
tions in premenarcheal girls who were a
younger subset (0–8 years of age) during
the exposure window in 1976. This age
stratum should capture any strong underly-
ing associations among girls exposed early
in life. However, it is known that pubertal
transition occurs around 5–7 years of age
and that age at menarche is strongly corre-
lated with age at first signs of development
(de Ridder et al. 1992; Nicolson and
Hanley 1953). Therefore, hormonal expo-
sures before 5 years of age might alter the
milestones of female development, includ-
ing menarche, either more potently or in a
different direction than peripubertal expo-
sures. Therefore, the youngest girls in this
population (Warner et al. 2004) may have
been more susceptible to hormonal effects
of environmental toxicants. Recognizing
the limitation of small numbers available
for further age stratification, it would be
interesting to know whether risk of earlier
(or later) puberty was raised among girls
exposed at earlier ages, such as 0–4 years.
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TCDD and Puberty: Warner and
Eskenazi Respond
As Wolff et al. note, in data from the Seveso
Women’s Health Study (SWHS) we found
no change in age of onset of menarche asso-
ciated with TCDD exposure in all women
in the cohort or in women exposed before
8 years of age (Warner et al. 2004).
However, Wolff et al. comment that hor-
monal exposures before 5 years of age might
be the more relevant time period, given that
the pubertal transition occurs around
5–7 years of age. Recognizing that our data
may be limited by small numbers, Wolff
et al. are interested in knowing whether risk
of earlier (or later) puberty was seen among
girls who were exposed before 5 years of age. 
Of the 282 women in the SWHS cohort
who were premenarcheal at the time of the
explosion on 10 July 1976, 84 women were
< 5 years of age. The mean age of menarche
reported for the 84 women was 12.6 ±
1.5 years, and the median lipid-adjusted
serum TCDD level was 233 ppt (range,
3.6–56,000 ppt). In Cox proportional haz-
ards models, when log10TCDD was entered
as the exposure variable, the hazard ratio
associated with a 10-fold increase in TCDD
was 1.2 [95% confidence interval, 0.98–1.6;
p for trend = 0.07]. That is, the risk of early
menarche was increased with the presence of
a 10-fold increase in serum TCDD level
(e.g., from 10 to 100 ppt), but not signifi-
cantly. The data were too sparse in the lower
exposure groups to perform categorical
analyses. The observed increase was limited
to the subset of women who were < 5 years
of age at exposure, as the effect was dimin-
ished when we considered including older
ages (< 6 years, < 7 years). 
In summary, the sample size is too
small to state with certainty, but it seems
that the women who received higher
exposure and were < 5 years of age at the
time of the explosion may have been at
somewhat increased risk for earlier menar-
che. As we stated in our article (Warner
et al. 2004), the women in this study
experienced significant TCDD exposure
during the postnatal but prepubertal
developmental period. Given that animal
evidence suggests in utero exposure can
affect onset of puberty, continued follow-
up of the offspring of the SWHS cohort is
important. 
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Comment on “Breast Milk:
An Optimal Food”
In their editorial “Breast Milk: An
Optimal Food,” Pronczuk et al. (2004)
stated that “in most cases, mothers can and
should be reassured that breast milk is by
far the best food to give to their babies,”
despite the evidence that “a myriad of
potential chemical contaminants … can be
detected in breast milk,” mainly because
a) levels of environmental contaminants,
as determined by subsequent surveys, con-
tinue to decrease; b) exposure through
ERRATA
Because the study “Threshold of Trichloroethylene Contamination in Maternal
Drinking Waters Affecting Fetal Heart Development in the Rat” (Johnson et al.
2003) was a long-term and continuous study, the authors compiled the data from con-
trols of several treatment groups. The control “sets” were statistically analyzed compar-
ing the data to each other before being combined. The authors opine that the control
values were statistically consistent across and throughout all the treatment groups.
Using the control data in a cumulative manner increased the generalizability of the
data, which purports to demonstrate the background rate and variability around rate
estimates. The larger sample size somewhat increased statistical power without the
inappropriate use of further valuable animal resources.
Table 1 presents the date ranges of experimental treatment and the coinciding con-
trol treatments. Each treatment exposure had a corresponding control group. Also,
because of the more detailed information on competing financial interests now included
in EHP’s Instructions to Authors, the authors now report that S.J. Goldberg served as
an expert witness for a plaintiff in a judicial hearing in 1997. As previously stated in a
prior letter to the editor (Johnson et al. 2004), at all times throughout this research, the
authors were free to design, conduct, interpret, and publish the research without com-
promise by any controlling sponsor as a condition of review or publication. 
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In “Environmental Health Disparities: A Framework Integrating Psychosocial and
Environmental Concepts” by Gee et al. [Environ Health Perspect 112:1645–1653
(2004)], the title of Figure 1 should be “Stress–exposure disease framework for
environmental health disparities.”
Table 1. Control versus TCE treatment groups and dates of exposure.
Control TCE
Fetuses/mothersa Dates Dose Fetuses/mothers Dates
135/15 14 Jun 1989–10 Oct 1992 1,100 ppm 105/9 29 Jun 1989–12 Mar 1990
155/13 11 Dec 1992–20 Oct 1993a 1.5 ppm 181/13 29 Dec 1989–26 Dec 1990
62/6 15 Apr 1994–23 May 1994a
120/10 6 Jul 1994–7 Jul 1995 2.5 ppb 144/12 6 Jun 1995–13 Jun 1995
134/11 18 Jul 1995–6 Oct 1995 250 ppb 110/9 5 Jul 1995–21 Jul 1995
aThe total number of control rat fetuses/mothers was 606/55. bOther studies that coincided with these control
groups were carried out during December 1989–June 1995 [e.g., metabolites that were reported in other articles
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breast milk may be less important than
exposure in utero; and c) there is little evi-
dence that exposure through breast milk is
associated with damage.
We believe that there is probably a
fourth good reason in support of their
recommendation. There is in fact some evi-
dence that breast-feeding may counteract
some of the negative effects of exposure to
environmental contaminants in utero. 
For example, Boersma and Lanting
(2000) showed that at 6 years of age cog-
nitive development is affected by prenatal
exposure to polychlorinated biphenyls
(PCBs) and dioxins. Breast-fed children,
however, when compared to formula-fed
children, had an advantage in terms of
quality of movements, fluency, and cogni-
tive development tests at 18 and
42 months of age and at 6 years of age,
despite a higher PCB exposure from
breast milk.
Ribas-Fito et al. (2003), studying a birth
cohort of 92 mother–infant pairs highly
exposed to organochlorine compounds,
found that prenatal exposure was associated
with a delay in mental and psychomotor
development at 13 months of age and that
long-term breast-feeding counterbalanced
this damage because it was associated with
better performance on both the mental and
motor scales compared to short-term or no
breast-feeding.
Vreugdenhil et al. (2004) found that
children who were breast-fed for at least
16 weeks did not show the delays in develop-
ment of the central nervous system that are
present in children breast-fed for 6–16 weeks
or formula-fed, despite a similar prenatal
exposure to PCBs.
This evidence is not conclusive (scientific
evidence rarely is), but we believe that it
should not be omitted in an article on
environmental contaminants and breast-
feeding.
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